Macter International Ltd. · PSX:MACTER

Macter International — H1 2024-25 Earnings Presentation

15 slides from Macter International's earnings presentation, Mar 11, 2025

  1. Slide 1: Macter International Limited Corporate Briefing Session

    Macter International Limited Corporate Briefing Session For the period ended December 31, 2024 Half Year 2024-25 March 11, 2025

  2. Slide 2: Disclaimer

    Disclaimer THIS PRESENTATION IS NOT AN OFFER OR SOLICITATION OF AN OFFER TO BUY OR SELL ANY SECURITIES OR ANY INVESTMENT This presentation has been prepared by Macter International Limited (“Macter”) solely for information purposes. No representation or warranty express or implied is made thereto, a

  3. Slide 3: Table of Content

    Table of Content 4 Financial Highlights 2 Pharmaceutical Market = 2©

  4. Slide 4: Financial Highlights

    Financial Highlights

  5. Slide 5: Financial Highlights - For the period ended December 31, 2024

    Financial Highlights - For the period ended December 31, 2024 Particulars HY 2024-25 HY 2023-24 Growth Sales 4,920 3581 37% Gross Profit 2,202 1454 51% Gross Margin 45% 41% Operating Profit 625 258 142% Profit After Tax 392 195 101% EPS 8.56 4.26 101%

  6. Slide 6: Performance Highlights For HY 2024-25

    Performance Highlights For HY 2024-25 Net turnover for the period ended 31st December 2024 was Rupees 4,920 million with a growth of 37%. All revenue categories (prescription, institution and export) registered high double digit growth which Sales reflects the company’s intent to significantly incre

  7. Slide 7: Net Sales, Profitability & Finance Cost Trend

    Net Sales, Profitability & Finance Cost Trend 8,000 50.00% 44.70% 45.00% 45.00% 7,000 42.22% 41.13% 41.69% 40.00% 6,000 36.85% 7,535 6,680 35.00% 5,000 30.00% 5,528 5,142 5,311 4,920 4,000 25.00% 20.00% 3,000 12.70% 15.00% 2,000 9.94% 9.46% 8.95% 9.25% 7.96% 10.00% 5.34% 5.99% 5.88% 5.67% 1,000 5.01

  8. Slide 8: Financial Highlights - Graphs

    Financial Highlights - Graphs Gross Margin (%) Earning Per Share (PKR) 10 9 8 7 6 44.70 42.22 45.00 41.13 41.69 5 9.32 36.85 8.58 8.56 4 7.19 6.57 3 2 1 0.38 FY20 FY21 FY22 FY23 FY24 HY24-25 0 FY20 FY21 FY22 FY23 FY24 HY24-25 Return on Capital Employed (%) *annualized basis Current Ratio 30 25 2 1.8

  9. Slide 9: Pakistan Pharma Market Overview

    Pakistan Pharma Market Overview

  10. Slide 10: Pakistan Pharma Market Evolution

    Pakistan Pharma Market Evolution Pharma Industry Market Share Trend Pakistan Pharma Market Evolution 80% 75% 800 758 72% 73% 69% 70% 70% 700 600 554 60% 477 500 50% 401 400 334 40% 31% 30% 249 28% 27% 300 30% 25% 196 158 177 200 136 20% 100 10% 0 FY20 FY21 FY22 FY23 FY24 0% FY20 FY21 FY22 FY23 FY24

  11. Slide 11: Industry Growth Dynamics

    Industry Growth Dynamics 24.00% 22.00% 22.00% 21.50% 20.30% 20.00% 19.90% 19.30% 18.70% 18.00% 17.20% 16.00% 15.60% 15.20% 14.00% 14.20% 12.00% 11.70% 12.10% 11.30% 10.80% 10.40% 10.00% FY20 FY21 FY22 FY23 FY24 MNC National Pharma Mkt

  12. Slide 12: Macter's Standing: +10 Billion Club

    Macter’s Standing: +10 Billion Club

  13. Slide 13: IQVIA Sales of Macter

    IQVIA Sales of Macter 12,000 MAT24 7,569 MAT23 6,802 MAT22 5,024 MAT21 4,133 MAT20 - 2,000 4,000 6,000 8,000 10,000 12,000 Sales

  14. Slide 14: IQVIA: Growth of Pharma Industry Vs Macter

    IQVIA: Growth of Pharma Industry Vs Macter 40.0 34.8 35.0 30.0 25.0 21.3 21.5 22.0 19.3 19.4 19.9 20.0 19.0 19.1 15.0 14.2 14.3 14.1 10.0 5.0 0.0 MONTH QTR MAT PHARMA INDUST. NATIONAL PHARMA MULTINATIONAL PHARMA MACTER INTERNATIONAL

  15. Slide 15: Thank You Q & A Session

    ® Macter Thank You Qa&A Session

Macter International — H1 2024-25 Earnings Presentation on 6ix